Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aluminum salt adjuvants (alum) are a class of adjuvants widely used in vaccines to enhance the immune response. They function by creating a depot effect, facilitating antigen uptake by antigen-presenting cells (APCs), activating the NLRP3 inflammasome, and stimulating the release of pro-inflammatory cytokines, ultimately leading to enhanced humoral immunity.
Aluminum salt adjuvants activate the innate immune system through mechanisms including the depot effect, phagocytosis by antigen-presenting cells (APCs), activation of the NLRP3 inflammasome, and promotion of pro-inflammatory cytokine release (IL-1β, IL-18), ultimately enhancing adaptive immune responses to co-administered antigens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aluminum Salt Adjuvant (Alum).